The American College of Neuropsychopharmacology (ACNP) held its 62nd annual meeting in Florida from the 3rd – 6th of December. For the past few years, psychedelics and related molecules have featured prominently at the meeting, demonstrating interest from the broader field. Indeed, at the European College of Neuropsychopharmacology’s (ECNP) meeting in October…

Source

Previous articlePT468 – Personalized Medicine, Biohacking, and Reconnecting to the Source
Next articlePT469 – Drug Policy in 2023: The FDA’s Guidance for Clinical Trials, The Natural Medicine Act, and SB-303